Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 12.9477 | 99 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 12.847 | 99 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 13.0357 | 99 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 13.3952 | 99 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 13.1361 | 99 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 12.8736 | 99 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 12.7936 | 99 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 13.2543 | 99 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 13.3396 | 99 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 13.0686 | 99 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 12.9853 | 99 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 13.1824 | 99 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 13.2086 | 99 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 13.1475 | 99 |